128 related articles for article (PubMed ID: 21291219)
1. 17β-estradiol-linked nitro-L-arginine as simultaneous inducer of apoptosis in melanoma and tumor-angiogenic vascular endothelial cells.
Roy S; Reddy BS; Sudhakar G; Kumar JM; Banerjee R
Mol Pharm; 2011 Apr; 8(2):350-9. PubMed ID: 21291219
[TBL] [Abstract][Full Text] [Related]
2. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
[TBL] [Abstract][Full Text] [Related]
4. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
[TBL] [Abstract][Full Text] [Related]
5. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
[TBL] [Abstract][Full Text] [Related]
7. Galactosyl derivative of N(omega)-nitro-L-arginine: study of antiproliferative activity on human thyroid follicular carcinoma cells.
Melisi D; Rosso F; Curcio A; Tortora C; Nieddu M; Marino G; Lettieri M; Grimaldi A; Luongo E; Romano S; Romano MF; Boatto G; Abignente E; Barbarisi A; Rimoli MG
J Cell Physiol; 2009 Nov; 221(2):440-7. PubMed ID: 19650107
[TBL] [Abstract][Full Text] [Related]
8. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM
Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876
[TBL] [Abstract][Full Text] [Related]
9. Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells.
Qiu H; Orr FW; Jensen D; Wang HH; McIntosh AR; Hasinoff BB; Nance DM; Pylypas S; Qi K; Song C; Muschel RJ; Al-Mehdi AB
Am J Pathol; 2003 Feb; 162(2):403-12. PubMed ID: 12547699
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG
Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506
[TBL] [Abstract][Full Text] [Related]
11. Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2.
Sakkoula E; Pipili-Synetos E; Maragoudakis ME
Br J Pharmacol; 1997 Nov; 122(5):793-5. PubMed ID: 9384490
[TBL] [Abstract][Full Text] [Related]
12. Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells.
Uhlmann S; Friedrichs U; Eichler W; Hoffmann S; Wiedemann P
Microvasc Res; 2001 Sep; 62(2):179-89. PubMed ID: 11516247
[TBL] [Abstract][Full Text] [Related]
13. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
[TBL] [Abstract][Full Text] [Related]
15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.
Geng L; Donnelly E; McMahon G; Lin PC; Sierra-Rivera E; Oshinka H; Hallahan DE
Cancer Res; 2001 Mar; 61(6):2413-9. PubMed ID: 11289107
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of tumor-draining lymph nodes and the nitric oxide pathway.
Davel L; Eijan AM; Sales ME; Español A; D'Agostino A; Piccardo I; Lauría L; De Lustig ES; Jasnis MA
Int J Oncol; 2002 Jan; 20(1):59-67. PubMed ID: 11743643
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture.
Di Pietro R; Mariggiò MA; Guarnieri S; Sancilio S; Giardinelli A; Di Silvestre S; Consoli A; Zauli G; Pandolfi A
J Cell Biochem; 2006 Mar; 97(4):782-94. PubMed ID: 16229016
[TBL] [Abstract][Full Text] [Related]
20. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways.
Souttou B; Raulais D; Vigny M
J Cell Physiol; 2001 Apr; 187(1):59-64. PubMed ID: 11241349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
